Ask a Question

User freezenation4

Member for: 1 month (since Mar 17)
Type: Registered user
Full name:
Location:
About: The use of erythropoiesis-stimulating agents with ruxolitinib inside individuals using myelofibrosis within COMFORT-II: a great open-label, cycle 3 research assessing efficiency and also basic safety regarding ruxolitinib compared to greatest obtainable therapy in the treatment of myelofibrosis.

Activity by freezenation4

Score: 0 points
Title: Newbie
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for freezenation4

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...